In 2023, Japan's government expenditure on R&D in medical and health sciences stood at an estimated baseline figure, with projected spending for 2024 onwards reflecting a consistent upward trend. Year-on-year increases are forecasted to be around 5% annually, indicating a significant and sustained investment in this sector. Over the five-year period leading to 2028, the compound annual growth rate (CAGR) remains similarly robust, suggesting a deliberate strategic focus on enhancing medical R&D capabilities.

Future trends to watch for include:

Influence of technological advancements and innovations on R&D expenditure.
Impact of demographic changes, particularly Japan's aging population, on healthcare demands and R&D priorities.
Government policies promoting international collaboration in medical research and their effect on domestic R&D funding.